Discover how BW successfully revived and completed a stalled GMP reconciliation project, paving the way for rectification and equalisation.
Author: Admin
How Narrow or Broad Are ACA Marketplace Physician Networks?
This report examines the share of doctors participating in the provider networks of Qualified Health Plans (QHPs) offered in the individual market in the federal and state Marketplaces in 2021, and how network breadth affected costs for enrollees.
KFF Analysis Finds Physician Networks in ACA Marketplace Plans Vary Widely, and Enrollees Typically Pay More in Premiums to Access Broader Networks
A KFF analysis of physician networks in the Affordable Care Act’s Marketplace plans finds wide variations in the share of local practicing physicians who participate, with the least costly plans generally having a smaller share of physicians than more expensive plans. The analysis examines the breadth of physician networks listed […]
Current issues in pensions financial reporting Q2 2024
This note for Q2 2024 delves into current issues for company directors when setting assumptions, and for auditors assessing their appropriateness.
Is it time to re-think how we model credit risk?
Why traditional credit risk models fall short and learn how to enhance your risk assessment. Our analysis reveals key factors for more accurate predictions.
Bridging the total rewards knowledge gap for employees
Lack of employee understanding or awareness around company benefits are a missed opportunity for both employer and employees.
Defined Benefit Funding Code of Practice
The Pensions Regulator (TPR) has published a new Code of Practice for funding DB pension schemes. We examine the possible impacts and the considerations for trustees.
Private equity: strategies for success in a shifting landscape
Assessing the risks and rewards in the evolving private equity landscape for long-term investors.
LGPS policy: is it about more than just the numbers?
The 2024 General Election has ushered in a new government. What does this mean for pensions, especially the LGPS, both now and in the future?
How many people with employer-sponsored insurance use the drugs slated for Medicare price negotiations
A new KFF analysis examines the number of enrollees in the employer-sponsored insurance market who use one or more of the ten drugs selected for Medicare Part D price negotiations. Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the 10 drugs. […]